Issue 5/2023
Content (9 Articles)
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure
- Hepatitis B
- Leading Article
Ming-Ling Chang, Yun-Fan Liaw
A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation
- Open Access
- Review Article
Nanthini Jayabalan, Bryan Oronsky, Pedro Cabrales, Tony Reid, Scott Caroen, Aishwarya M. Johnson, Natalia A. Birch, John D. O’Sullivan, Richard Gordon
Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
- Dyslipidemia
- Systematic Review
Joseph E. Blais, Xin Huang, Jie V. Zhao
Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study
- Open Access
- Pre-Eclampsia
- Original Research Article
Grégory Lailler, Clémence Grave, Amélie Gabet, Nolwenn Regnault, Catherine Deneux-Tharaux, Sandrine Kretz, Vassilis Tsatsaris, Geneviève Plu-Bureau, Jacques Blacher, Valérie Olie
Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”
- Erectile Dysfunction
- Letter to the Editor
Jin-Xian Huang, Guo-Wen Zhang
Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”
- Erectile Dysfunction
- Letter to the Editor
Qiang Tong, Shiow-Ing Wang, James Cheng-Chung Wei, Sheng-Ming Dai